Ozempic is approved for managing type 2 diabetes
Novo Nordisk Inc and Novo Nordisk A/S v Viatris Inc and Mylan Pharmaceuticals, 1:23-cv-00101 and Novo Nordisk Inc and Novo Nordisk A/S v Sun Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries, Inc, 1:23-cv-01459 17 The drop in patent filings observed in 2023 may reflect several factors
This protein binds specifically to reduced glutathione (GSH) in near-neutral, nondenaturing conditions (e.g., Tris buffer)
Additionally, it resets gene expression, combats inflammation, and supports antioxidant activity, making it a versatile solution for rejuvenating aging skin and hair
no clinical trials validate the combination
All materials should be handled by qualified personnel in accordance with applicable laboratory safety and regulatory requirements